Clinical Report: What to Expect at ASRS 2026
Overview
The ASRS 2026 meeting in Montreal will feature surgical sessions, including a focus on international surgeons and a session on complications faced by young surgeons. The program aims to provide educational opportunities and networking for attendees.
Background
The American Society of Retina Specialists (ASRS) annual meeting is a significant event for ophthalmologists, providing a platform for advancements in retina surgery and treatment. The 2026 meeting will emphasize emerging therapies and real-world applications in the management of retinal diseases.
Data Highlights
No numerical data provided in the source material.
Key Findings
- The meeting will start with 'Retina Surgery Around the Globe,' highlighting international surgical practices.
- A new session titled 'Circus of Complications' will feature discussions by young surgeons on complications encountered in practice.
- Focus areas will include age-related macular degeneration (AMD) and emerging therapies in geographic atrophy.
- Networking opportunities and social activities are planned to enhance attendee engagement.
- The program aims to be memorable and impactful for all participants.
Clinical Implications
Healthcare professionals attending the ASRS 2026 meeting will gain insights into surgical techniques and complications management in retina surgery.
Conclusion
The ASRS 2026 meeting will focus on education, innovation, and community building.
Related Resources & Content
- retinal physician, 2025 -- Incoming ASRS President Shares Vision for Future
- ophthalmology management, 2025 -- ASCRS 2025 to Meet in Los Angeles
- Ophthalmology Management, 2021 -- ASCRS prepares for in-person meeting in Las Vegas
- 2026 Annual Meeting Program - The American Society of Retina Specialists
- Ophthalmology Management — ASCRS 2021 prepares for Vegas
- ASRS 2026 Annual Meeting Program Highlights
- Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial - ScienceDirect
- Real-world Safety Profile of Avacincaptad Pegol in the Management of Geographic Atrophy | Ophthalmic Surgery, Lasers and Imaging Retina
- Complement Inhibition in Geographic Atrophy: Clinical Evidence for Pegcetacoplan and Avacincaptad Pegol - PMC
- SYFOVRE (pegcetacoplan injection) Prescribing Information
- AAV-based gene therapies for neovascular AMD | Gene Therapy
- Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial - PubMed
- Intraocular Pressure Outcomes with Intravitreal Aflibercept 8 mg: A 96-Week Pooled Analysis from PULSAR and PHOTON - PubMed
- Intraocular Pressure Outcomes with Intravitreal Aflibercept 8 mg: A 96-Week Pooled Analysis from PULSAR and PHOTON | Ophthalmology and Therapy | Springer Nature Link
- Rapid Fluid Resolution and Faricimab Durability in nAMD: TENAYA/LUCERNE Post Hoc Findings - Be part of the knowledge - ReachMD
- 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 - PMC
- Section 12: Retinopathy, Neuropathy, and Foot Care | Diabetes, Obesity, and Cardiometabolic CARE | American Diabetes Association
- THERAPEUTICS FOR MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY RELATED TO RHEGMATOGENOUS RETINAL DETACHMENT: A Network Meta-Analysis
- Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: A systematic review and meta-analysis - PubMed
- Comparative outcomes of focal laser versus 360-degree laser in vitrectomy for retinal detachment: a systematic review and meta-analysis | International Journal of Retina and Vitreous | Springer Nature Link
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
